One of the very important things I learned while in israel was that the company has been hampered by regulatory delays...just like many other Israeli companies....
THis has contributed to a lot of our anxieties as shareholders because the company never feels the need to communicate these types of issues with us.

As far as patent progress... I leave that to the specialists that work on the company portfolio.

My concern has never been with the science.

It has always been with their poor communication efforts with their shareholders who help to fund company operations.

They just don't seem to get it...and that there is a massive need for an investor relations person that would take the pressure off of receiving dozens of emails weekly by management of which many I am sure are disgusting...

We continue to press the company on this issue and once again have emphasised the need for communication with the shareholder base and not just through SEC filings or the sporadic release of the chairman's letter.